Catalyst Wire Dossier Catalyst Wire Dossier

CMS-D001

· Dermavon Holdings Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CMS-D001, covering 2026-02-25 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With Moderate to Severe Atopic Dermatitis [Phase 2]

See pricing